Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.
Liver cells expressing high levels of telomerase – a protein normally associated with resistance to aging and implicated in cancers and stem cell maintenance – are necessary to regenerate the organ after normal cell turnover or in response to damage.
A new study found that oncologists have divergent views on how to use “value” to guide cancer treatment recommendations.
Breast cancer in men and women differ in levels of cancer-associated gene expression and the relative risk of recurrence after initially successful treatment. Some men have a higher risk than women, whereas others have a much lower risk.
Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.
According to Stanford pediatric oncologist Crystal Mackall, a pediatric oncologist with Stanford Children's Health, immunotherapy with CAR T cells is more precise, more specific and just as potent a treatment for leukemia as chemotherapy.
On the Future of Everything radio show, Stanford bioengineer Jennifer Cochran discusses her development of "tumor-targeting missiles" that deliver chemotherapy as "cargo" to more effectively kill cancer.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
Stanford Storybank, organized by Stanford Health Care, collects 40-minute audio stories from patients and members of the Stanford Medicine community.
After Aditi Polamreddy's brain tumor was removed, she needed physical and occupational therapy to keep her brain from forgetting one side of her body.
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
